2 active not recruiting, 2 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 2, Completed 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow X-Linked Retinitis Pigmentosa: new trials by email Literature Review of X-Linked Retinitis Pigmentosa trials Research Report on X-Linked Retinitis Pigmentosa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP rAAV2tYF-GRK1-hRPGRco, Control - X-Linked Retinitis Pigmentosa | Phase 2 / Phase 3 | Active not recruiting | Beacon Therapeutics | 85 | 2024-03-14 | 2026-04-07 |
| Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Genetic: AAV5-hRKp.RPGR Intermediate Dose, Genetic: AAV5-hRKp.RPGR Low Dose - X-Linked Retinitis Pigmentosa | Phase 3 | Active not recruiting | MeiraGTx Ocular UK Ltd | 97 | 2020-12-04 | 2026-09-25 |
| Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Genetic: AAV5-hRKp.RPGR - X-Linked Retinitis Pigmentosa | Phase 3 | Completed | MeiraGTx Ocular UK Ltd | 105 | 2020-12-04 | 2026-09-24 |
| Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa BIIB111, BIIB112 - Choroideremia, X-Linked Retinitis Pigmentosa | Phase 3 | Completed | NightstaRx Ltd, a Biogen Company | 277 | 2018-06-04 | 2026-07-06 |
Choroideremia (1) · Retinal Degeneration (1)
Eye Diseases (2) · Eye Diseases, Hereditary (2) · Choroid Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Retinal Diseases (1) · Uveal Diseases (1)
MeiraGTx Ocular UK Ltd (2) · Beacon Therapeutics (1) · NightstaRx Ltd, a Biogen Company (1)
Canada (4) · United Kingdom (4) · United States (4) · Denmark (3) · France (3) · Netherlands (3) · Belgium (2) · Israel (2) · Italy (2) · Spain (2) · Switzerland (2) · Australia (1) · Brazil (1) · Finland (1) · Germany (1)
Carrie Reichley (1)
2017 (1)